Delaware | 001-37586 | 47-4027764 |
(State of other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification No.) |
5255 Virginia Avenue | ||
North Charleston, South Carolina 29406 | ||
(Address of principal executive offices) (Zip code) |
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: | |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). | |
Emerging growth company o | |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act o |
(a) | Financial Statements of the Business Acquired |
(i) | Audited Combined Financial Statements as of and for the year ended December 31, 2016 of the Pine Chemical Business are attached as Exhibit 99.1 to this Current Report on Form 8-K/A. |
(ii) | Unaudited Combined Balance Sheet as of September 30, 2017 and December 31, 2016 and the related unaudited Combined Statements of Operations, Changes in Parent Company Net Investment and Cash Flows for the nine month periods ended September 30, 2017 and 2016 of the Pine Chemical Business are attached as Exhibit 99.2 to this Current Report on Form 8-K/A. |
(b) | Pro Forma Financial Information |
(i) | Unaudited Pro Forma Condensed Combined Balance Sheet as of December 31, 2017. |
(ii) | Unaudited Pro Forma Condensed Combined Statement of Operations for the year ended December 31, 2017. |
(d) | Exhibits |
Exhibit No. | Description of Exhibit |
Consent of Ernst & Young LLP, Independent Auditor. | |
Pine Chemical Business Audited Combined Financial Statements as of and for the year ended December 31, 2016. | |
Pine Chemical Business Unaudited Combined Balance Sheet as of September 30, 2017 and December 31, 2016 and the related unaudited Combined Statements of Operations, Changes in Parent Company Net Investment and Cash Flows for the nine month periods ended September 30, 2017 and 2016. | |
Unaudited Pro Forma Condensed Combined Financial Information. |
INGEVITY CORPORATION | |
(Registrant) | |
By: | /S/ JOHN C. FORTSON |
John C. Fortson | |
Executive Vice President, Chief Financial Officer and Treasurer |
Notes | 2016 | |||||
ASSETS | ||||||
Current assets: | ||||||
Accounts receivable, net | Note 2 | $ | 10,920 | |||
Inventories | Note 3 | 7,043 | ||||
Other current assets | Note 4 | 2,119 | ||||
Related party receivables | Note 8 | 674 | ||||
Total current assets | 20,756 | |||||
Property, plant and equipment, net | Note 5 | 36,061 | ||||
Other assets | Note 5 | 845 | ||||
Total assets | $ | 57,662 | ||||
LIABILITIES AND EQUITY | ||||||
Current liabilities: | ||||||
Accounts payable | $ | 1,988 | ||||
Other current liabilities | 504 | |||||
Related party payables | Note 8 | 10 | ||||
Total current liabilities | 2,502 | |||||
Deferred income taxes | Note 6 | 12,281 | ||||
Total liabilities | 14,783 | |||||
Parent company net investment | 42,879 | |||||
Total liabilities and parent company net investment | $ | 57,662 |
Notes | 2016 | |||||
Sales and operating revenues | Note 9 | $ | 103,202 | |||
Costs and operating expenses | ||||||
Cost of sales | Note 7 and 10 | 83,649 | ||||
Selling, general and administrative | Note 1 and 8 | 6,625 | ||||
Depreciation and amortization | Note 5 | 7,480 | ||||
Total costs and operating expenses | 97,754 | |||||
Income from operations | 5,448 | |||||
Other loss, net | 1 | |||||
Income before taxes | 5,447 | |||||
Income tax expense | Note 6 | 1,775 | ||||
Net income | $ | 3,672 |
Notes | 2016 | ||||
Balance as of December 31, 2015 | $ | 50,441 | |||
Net income | 3,672 | ||||
Net transfer to Parent | (11,234) | ||||
Balance as of December 31, 2016 | $ | 42,879 | |||
2016 | |||||
Cash flows from operating activities: | |||||
Net income | $ | 3,672 | |||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||
Depreciation and amortization | 7,480 | ||||
Deferred tax (benefit) | (2,309 | ) | |||
(Gain)/loss on sale of property | 1 | ||||
Net change in operating assets and liabilities | |||||
Accounts receivable | 217 | ||||
Inventories | 6,397 | ||||
Accounts payable | (2,020 | ) | |||
Other working capital | (281 | ) | |||
Turnaround expenditures | (23 | ) | |||
Net cash provided by operating activities | 13,134 | ||||
Cash flows from investing activities: | |||||
Capital expenditures | (1,900 | ) | |||
Net cash used in investing activities | (1,900 | ) | |||
Cash flows from financing activities: | |||||
Net transfers to Parent Company | (11,234 | ) | |||
Net cash used in financing activities | (11,234 | ) | |||
Net increase (decrease) in cash and cash equivalents | — | ||||
Cash and cash equivalents, beginning of year | — | ||||
Cash and cash equivalents, end of year | $ | — | |||
2016 | |||
Accounts receivable | $ | 11,122 | |
Allowance for doubtful accounts | (202) | ||
Total accounts receivable, net | $ | 10,920 |
2016 | |||
Finished goods | $ | 5,487 | |
Raw materials | 2,151 | ||
Supplies | 438 | ||
LIFO reserve | (1,033) | ||
Total inventories | $ | 7,043 |
Estimated Useful Life | 2016 | ||||
(in years) | |||||
Machinery and equipment | 3 – 20 | $ | 71,000 | ||
Buildings | 20 – 45 | 2,805 | |||
Land and improvements | 15 – 30 | 195 | |||
Construction in progress | 1,500 | ||||
Property, plant and equipment, at cost | 75,500 | ||||
Accumulated depreciation | (39,439) | ||||
Property, plant and equipment, net | $ | 36,061 |
2016 | |||
Current income taxes: | |||
U.S. Federal | $ | 3,365 | |
U.S. State | 719 | ||
Total current income taxes | 4,084 | ||
Deferred income taxes: | |||
U.S. federal | $ | (2,019 | ) |
U.S. state and local | (218 | ) | |
Total deferred income taxes | (2,309 | ) | |
Provision for income taxes | $ | 1,775 |
2016 | |||
Net Income before income taxes | $ | 5,447 | |
U.S. statutory income tax rate | 35.0 | % | |
Tax expense at U.S. statutory income tax rate | 1,906 | ||
State and Local income taxes | 326 | ||
Other | (113 | ) | |
Domestic Manufacturing Deduction | (344 | ) | |
Income Tax Provision | $ | 1,775 | |
Effective Tax Rate | 32.6 | % |
2016 | |||
Deferred tax assets: | |||
Allowance for doubtful accounts | $ | 75 | |
Total deferred tax assets | $ | 75 | |
Deferred tax liabilities: | |||
PP&E | (10,879) | ||
Inventory | (1,147) | ||
Turnaround | (330) | ||
Total deferred tax liabilities | (12,356) | ||
Net deferred tax liabilities | $ | (12,281) | |
2016 | |||
Corporate and building products segment costs | $ | 3,048 | |
Chemical division costs | 6,768 | ||
Total Allocated Costs | $ | 9,816 | |
Notes | September 30, 2017 | December 31, 2016 | |||||||
ASSETS | (unaudited) | ||||||||
Current assets: | |||||||||
Accounts receivable, net | Note 2 | $ | 14,301 | $ | 10,920 | ||||
Inventories | Note 3 | 9,924 | 7,043 | ||||||
Other current assets | Note 4 | 2,400 | 2,119 | ||||||
Related party receivables | Note 8 | 334 | 674 | ||||||
Total current assets | 26,959 | 20,756 | |||||||
Property, plant and equipment, net | Note 5 | 33,547 | 36,061 | ||||||
Other assets | Note 5 | 150 | 845 | ||||||
Total assets | $ | 60,656 | $ | 57,662 | |||||
LIABILITIES AND EQUITY | |||||||||
Current liabilities: | |||||||||
Accounts payable | $ | 2,346 | $ | 1,988 | |||||
Other current liabilities | 626 | 504 | |||||||
Related party payables | Note 8 | 4 | 10 | ||||||
Total current liabilities | 2,976 | 2,502 | |||||||
Deferred income taxes | Note 6 | 11,545 | 12,281 | ||||||
Total liabilities | 14,521 | 14,783 | |||||||
Parent company net investment | 46,135 | 42,879 | |||||||
Total liabilities and parent company net investment | $ | 60,656 | $ | 57,662 |
Nine Months Ended | ||||||||||||
Notes | September 30, 2017 | September 30, 2016 | ||||||||||
(unaudited) | ||||||||||||
Sales and operating revenues | Note 9 | $ | 76,256 | $ | 78,841 | |||||||
Costs and operating expenses | ||||||||||||
Cost of sales | Notes 7 and 10 | 58,342 | 63,427 | |||||||||
Selling, general and administrative | Notes 1 and 8 | 5,219 | 5,026 | |||||||||
Depreciation and amortization | Note 5 | 4,427 | 5,758 | |||||||||
Total costs and operating expenses | 67,988 | 74,211 | ||||||||||
Income from operations | 8,268 | 4,630 | ||||||||||
Other loss, net | — | 1 | ||||||||||
Income before taxes | 8,268 | 4,629 | ||||||||||
Income tax expense | Note 6 | 2,845 | 1,523 | |||||||||
Net income | $ | 5,423 | $ | 3,106 |
Nine Months Ended | ||||||||||
Notes | September 30, 2017 | September 30, 2016 | ||||||||
(unaudited) | ||||||||||
Parent company net investment, beginning of period | $ | 42,879 | $ | 50,441 | ||||||
Net income | 5,423 | 3,106 | ||||||||
Net transfer to Parent | (2,167 | ) | (9,723 | ) | ||||||
Parent company net investment, end of period | $ | 46,135 | $ | 43,824 | ||||||
Nine Months Ended | |||||||
September 30, 2017 | September 30, 2016 | ||||||
(unaudited) | |||||||
Cash flows from operating activities: | |||||||
Net income | $ | 5,423 | $ | 3,106 | |||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
Depreciation and amortization | 4,427 | 5,758 | |||||
Deferred tax (benefit) | (736 | ) | (1,947 | ) | |||
(Gain)/loss on sale of property | 44 | 1 | |||||
Net change in operating assets and liabilities: | |||||||
Accounts receivable | (3,041 | ) | 585 | ||||
Inventories | (2,881 | ) | 5,444 | ||||
Accounts payable | 352 | (1,804 | ) | ||||
Other working capital | (160 | ) | (103 | ) | |||
Turnaround expenditures | — | (23 | ) | ||||
Net cash provided by operating activities | 3,428 | 11,017 | |||||
Cash flows from investing activities: | |||||||
Capital expenditures | (1,261 | ) | (1,294 | ) | |||
Net cash used in investing activities | (1,261 | ) | (1,294 | ) | |||
Cash flows from financing activities: | |||||||
Net transfers to Parent Company | (2,167 | ) | (9,723 | ) | |||
Net cash used in financing activities | (2,167 | ) | (9,723 | ) | |||
Net increase (decrease) in cash and cash equivalents | — | — | |||||
Cash and cash equivalents, beginning of period | — | — | |||||
Cash and cash equivalents, end of period | $ | — | $ | — |
September 30, 2017 | December 31, 2016 | |||||||||||
(unaudited) | ||||||||||||
Accounts receivable | $ | 14,606 | $ | 11,122 | ||||||||
Allowance for doubtful accounts | (305) | (202) | ||||||||||
Total accounts receivable, net | $ | 14,301 | $ | 10,920 |
September 30, 2017 | December 31, 2016 | ||||||||||||
(unaudited) | |||||||||||||
Finished goods | $ | 7,223 | $ | 5,487 | |||||||||
Raw materials | 1,629 | 2,151 | |||||||||||
Supplies | 387 | 438 | |||||||||||
LIFO reserve | 685 | (1,033 | ) | ||||||||||
Total inventories | $ | 9,924 | $ | 7,043 |
Estimated Useful Life | September 30, 2017 | December 31, 2016 | ||||||||||||||
(in years) | (unaudited) | |||||||||||||||
Machinery and equipment | 3 – 20 | $ | 73,128 | $ | 71,000 | |||||||||||
Buildings | 20 – 45 | 3,021 | 2,805 | |||||||||||||
Land and improvements | 15 – 30 | 195 | 195 | |||||||||||||
Construction in progress | 208 | 1,500 | ||||||||||||||
Property, plant and equipment, at cost | 76,552 | 75,500 | ||||||||||||||
Accumulated depreciation | (43,005 | ) | (39,439 | ) | ||||||||||||
Property, plant and equipment, net | $ | 33,547 | $ | 36,061 |
Nine Months Ended | |||||||||||||||
September 30, 2017 | September 30, 2016 | ||||||||||||||
(unaudited) | |||||||||||||||
Corporate and building products segment costs | $ | 1,841 | $ | 2,277 | |||||||||||
Chemical division costs | 5,525 | 5,471 | |||||||||||||
Total Allocated Costs | $ | 7,366 | $ | 7,748 |
• | The accompanying notes to the unaudited pro forma condensed consolidated financial information; |
• | Pine Chemical Business Audited Combined Financial Statements as of and for the year ended December 31, 2016 and related notes thereto attached as Exhibit 99.1 to this Current Report on Form 8-K/A; |
• | Pine Chemical Business Unaudited Combined Balance Sheet as of September 30, 2017 and December 31, 2016 and the related unaudited Combined Statements of Operations, Changes in Parent Company Net Investment and Cash Flows for the nine month periods ended September 30, 2017 and 2016 and related notes thereto attached as Exhibit 99.2 to this Current Report on Form 8-K/A; and |
• | Ingevity Corporation Consolidated Financial Statements as of and for the year ended December 31, 2017 and related notes thereto contained in its Annual Report on Form 10-K filed with the SEC on February 28, 2018. |
INGEVITY CORPORATION | |||||||||||||||||
UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET | |||||||||||||||||
AS OF DECEMBER 31, 2017 | |||||||||||||||||
(in millions) | Historical Ingevity | Pine Chemical Business (Note 1) | Pro Forma Adjustments | Note 2 | Ingevity Pro Forma | ||||||||||||
Assets | |||||||||||||||||
Cash and cash equivalents | $ | 87.9 | $ | — | $ | (24.5 | ) | A | $ | 63.4 | |||||||
Accounts receivable, net | 100.0 | 14.6 | — | 114.6 | |||||||||||||
Inventories, net | 160.0 | 12.0 | 1.7 | B | 173.7 | ||||||||||||
Prepaid and other current assets | 20.8 | 0.3 | — | 21.1 | |||||||||||||
Current assets | 368.7 | 26.9 | (22.8 | ) | 372.8 | ||||||||||||
Property, plant and equipment, net | 438.5 | 33.5 | 6.8 | C | 478.8 | ||||||||||||
Goodwill | 12.4 | — | 115.8 | D | 128.2 | ||||||||||||
Other intangibles, net | 4.9 | — | 133.1 | E | 138.0 | ||||||||||||
Deferred income taxes | 3.4 | — | — | 3.4 | |||||||||||||
Restricted investment | 71.3 | — | — | 71.3 | |||||||||||||
Other assets | 30.4 | 0.2 | — | F | 30.6 | ||||||||||||
Total Assets | $ | 929.6 | $ | 60.6 | $ | 232.9 | $ | 1,223.1 | |||||||||
Liabilities and Equity | |||||||||||||||||
Accounts payable | $ | 83.1 | $ | 2.4 | $ | — | $ | 85.5 | |||||||||
Accrued expenses | 20.0 | 0.6 | — | 20.6 | |||||||||||||
Accrued payroll and employee benefits | 39.2 | — | — | 39.2 | |||||||||||||
Current maturities of long-term debt | 9.4 | — | — | 9.4 | |||||||||||||
Income taxes payable | 1.5 | — | — | 1.5 | |||||||||||||
Current liabilities | 153.2 | 3.0 | — | 156.2 | |||||||||||||
Long-term debt including capital lease obligations | 444.0 | — | 294.3 | G | 738.3 | ||||||||||||
Deferred income taxes | 41.3 | 11.5 | (11.5 | ) | H | 41.3 | |||||||||||
Other liabilities | 13.2 | — | — | 13.2 | |||||||||||||
Total Liabilities | 651.7 | 14.5 | 282.8 | 949.0 | |||||||||||||
Equity | |||||||||||||||||
Preferred stock | — | — | — | — | |||||||||||||
Common stock | 0.4 | — | — | 0.4 | |||||||||||||
Additional paid-in capital | 140.1 | — | — | 140.1 | |||||||||||||
Retained earnings | 142.8 | — | (3.8 | ) | I | 139.0 | |||||||||||
Accumulated other comprehensive loss | (11.7 | ) | — | — | (11.7 | ) | |||||||||||
Treasury stock, common stock, at cost | (7.7 | ) | — | — | (7.7 | ) | |||||||||||
Parent company net investment | — | 46.1 | (46.1 | ) | J | — | |||||||||||
Total Ingevity stockholders' equity | 263.9 | 46.1 | (49.9 | ) | 260.1 | ||||||||||||
Noncontrolling interests | 14.0 | — | — | 14.0 | |||||||||||||
Total Equity | 277.9 | 46.1 | (49.9 | ) | 274.1 | ||||||||||||
Total Liabilities and Equity | $ | 929.6 | $ | 60.6 | $ | 232.9 | $ | 1,223.1 |
INGEVITY CORPORATION | |||||||||||||||
UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS | |||||||||||||||
FOR THE YEAR ENDED DECEMBER 31, 2017 | |||||||||||||||
(in millions, except per share data) | Historical Ingevity | Pine Chemical Business (Note 1) | Pro Forma Adjustments | Note 2 | Ingevity Pro Forma | ||||||||||
Net sales | $ | 972.4 | $ | 100.6 | $ | — | $ | 1,073.0 | |||||||
Cost of sales | 643.4 | 84.7 | (12.7 | ) | K | 715.4 | |||||||||
Gross profit | 329.0 | 15.9 | 12.7 | 357.6 | |||||||||||
Selling, general and administrative expenses | 106.4 | 6.8 | 12.6 | L | 125.8 | ||||||||||
Research and technical expenses | 19.8 | — | — | 19.8 | |||||||||||
Separation expense | 0.9 | — | — | 0.9 | |||||||||||
Restructuring and other (income) charges, net | 3.7 | — | — | 3.7 | |||||||||||
Acquisition costs | 7.1 | — | (7.1 | ) | M | — | |||||||||
Other (income) expense, net | 0.5 | — | — | 0.5 | |||||||||||
Interest expense | 18.1 | — | 14.2 | G | 32.3 | ||||||||||
Interest income | (2.3 | ) | — | — | (2.3 | ) | |||||||||
Income (loss) before income taxes | 174.8 | 9.1 | (7.0 | ) | 176.9 | ||||||||||
Provision (benefit) for income taxes | 29.6 | 3.1 | (2.6 | ) | N | 30.1 | |||||||||
Net income (loss) | 145.2 | 6.0 | (4.4 | ) | 146.8 | ||||||||||
Less: Net income (loss) attributable to noncontrolling interests | 18.7 | — | — | 18.7 | |||||||||||
Net income (loss) attributable to Ingevity stockholders | $ | 126.5 | $ | 6.0 | $ | (4.4 | ) | $ | 128.1 | ||||||
Net income (loss) per share | |||||||||||||||
Basic | $ | 3.00 | $ | 3.04 | |||||||||||
Diluted | $ | 2.97 | $ | 3.01 | |||||||||||
Weighted average shares outstanding (in thousands) | |||||||||||||||
Basic | 42,130 | 42,130 | |||||||||||||
Diluted | 42,529 | 42,529 |
1. | Pine Chemical Business historical financial statements |
• | $0.3 million of related party receivables between the Pine Chemical Business and subsidiaries of Koch Industries, Inc., the parent organization for Georgia-Pacific, were reclassified to accounts receivable, net. |
• | $2.1 million of other current assets related to storeroom supplies were reclassified to inventories, net. |
• | $6.1 million of depreciation and amortization expenses were reclassified to cost of sales. |
2. | Pro Forma Adjustments |
Amount | |||
Current assets | $ | 28.6 | |
Property, plant, and equipment, net | 40.3 | ||
Other intangibles, net | 133.1 | ||
Other assets | 0.2 | ||
Total assets acquired | 202.2 | ||
Total current liabilities | (3.0) | ||
Total liabilities assumed | (3.0) | ||
Net identifiable assets acquired | 199.2 | ||
Goodwill | 115.8 | ||
Total consideration transferred | $ | 315.0 |
A. | Cash and cash equivalents |
Amount | |||
Net proceeds from senior notes (1) | $ | 294.3 | |
Consideration transferred (2) | (315.0 | ) | |
Acquisition-related transaction costs (3) | (3.8 | ) | |
Total pro forma adjustment to cash and cash equivalents | $ | (24.5 | ) |
B. | Inventories, net |
C. | Property, plant and equipment, net |
Amount | |||
Preliminary fair value adjustment (1) | $ | 12.9 | |
Excluded property, plant and equipment (2) | (6.1 | ) | |
Total pro forma adjustment to property, plant and equipment | $ | 6.8 |
(1) | Represents the estimated fair value adjustment to Pine Chemical Business property, plant and equipment: |
Preliminary Fair Value | Average Estimated Remaining Useful Life in Years | Depreciation expense Year ended December 31, 2017 | ||||||||
Machinery and equipment | $ | 35.5 | 9 | $ | 4.7 | |||||
Buildings and leasehold equipment | 2.8 | 15 | 0.2 | |||||||
Land and land improvements | 2.0 | 5 | 0.2 | |||||||
Total | $ | 40.3 | $ | 5.1 | ||||||
Less: depreciation expense for excluded assets | (0.7 | ) | ||||||||
Less: depreciation expense for acquired assets included in historical statement of operations of the Pine Chemical Business | (4.2 | ) | ||||||||
Net pro forma adjustment to depreciation expense | $ | 0.2 |
(2) | To adjust certain assets included in the Pine Chemical Business historical balance sheet that will not be transferred in accordance with the Asset Purchase Agreement. |
D. | Goodwill |
E. | Other intangibles, net |
Preliminary Fair Value | Average Estimated Remaining Useful Life in Years | Amortization expense Year ended December 31, 2017 | ||||||||
Customer relationships | $ | 129.0 | 11 | $ | 11.7 | |||||
Patents | 1.9 | 12 | 0.2 | |||||||
Noncompetition agreements | 2.2 | 3 | 0.7 | |||||||
Total | $ | 133.1 | $ | 12.6 |
F. | Other assets |
Amount | |||
Preliminary fair value adjustment of identified other assets (1) | $ | 0.2 | |
Reversal of historically capitalized planned major maintenance activities costs (2) | (0.2 | ) | |
Total pro forma adjustment to other assets | $ | 0.0 |
(1) | Represents an adjustment to record an asset associated with an acquired operating lease with below-market terms at fair value. The estimated useful life of this intangible asset is based on the lease term of 50 years. Pro forma amortization for the year ended December 31, 2017 was less than $0.1 million. |
(2) | Represents costs capitalized for planned major maintenance activities, which were determined to have an acquisition date fair value of zero. |
G. | Long-term debt and interest expense |
Amount | |||
Total private placement (8-year senior unsecured notes) | $ | 300.0 | |
Debt issuance costs | (5.7 | ) | |
Total pro forma adjustment to Ingevity's long-term debt | $ | 294.3 |
Amount | |||
Interest expense on new long term debt | $ | 13.5 | |
Amortization of new debt issuance costs | 0.7 | ||
Total pro forma adjustment to Ingevity's interest expense | $ | 14.2 |
H. | Deferred income taxes |
I. | Retained earnings |
J. | Parent company net investment |
Amount | |||
Excluded assets (1) | $ | (6.1 | ) |
Elimination of remaining historical parent investment (2) | (40.0 | ) | |
Total pro forma adjustment to parent company net investment | $ | (46.1 | ) |
(1) | Represents the adjustment to the Pine Chemical Business historical parent company net investment balance for property, plant and equipment of the Pine Chemical Business not transferred to Ingevity in accordance with the Asset Purchase Agreement; see Note 2(C). |
(2) | Relates to the elimination of Georgia-Pacific’s investment in the Pine Chemical Business. |
K. | Cost of sales |
Amount | |||
Total pro forma adjustment to depreciation of acquired property, plants and equipment (1) | $ | 0.2 | |
Pro forma adjustment to remove historical amortization of planned major maintenance activities costs (2) | (1.2 | ) | |
Adjustment from historical transfer pricing to market-based pricing per long term supply agreement (3) | (11.7 | ) | |
Total pro forma adjustment to cost of sales | $ | (12.7 | ) |
(1) | Represents the adjustment to Pine Chemical Business historical depreciation as a result of preliminary fair value adjustments to the acquired depreciable assets and adjustments to their respective estimated remaining useful lives; see Note 2(C). |
(2) | Represents the adjustment to Pine Chemical Business historical amortization of planned major maintenance activities costs that were determined to have a preliminary acquisition date fair value of zero; see Note 2(F). |
(3) | Relates to a long-term supply agreement between Ingevity and Georgia-Pacific for the purchase of crude tall oil (“CTO”). The supply agreement was entered into on March 8, 2018 whereby Ingevity has agreed to purchase CTO originating from Georgia-Pacific mills at market-based prices for a term of 20 years. |
L. | Selling, general and administrative expenses |
M. | Acquisition costs |
N. | Provision (benefit) for income taxes |